In early data, rates of seropositivity following one and two doses of COVID‐19 vaccine were lowest in chronic lymphocytic leukaemia (CLL) patients and in patients treated with BTK inhibitors [1]. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.